These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27730628)

  • 21. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate Psoriasis: A Proposed Definition.
    Llamas-Velasco M; de la Cueva P; Notario J; Martínez-Pilar L; Martorell A; Moreno-Ramírez D
    Actas Dermosifiliogr; 2017 Dec; 108(10):911-917. PubMed ID: 28823420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
    Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translation into Spanish and field-testing of a new score for evaluating psoriasis severity: The Simplified Psoriasis Index (SPI).
    Barquero-Orias DE; Armellini E; Anderson AJ; Armellini A; Ortega-Loayza AG; Helbling I; Chalmers RJG
    Actas Dermosifiliogr; 2022 Apr; 113(4):363-369. PubMed ID: 35623726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis.
    Bagel J
    J Drugs Dermatol; 2011 Apr; 10(4):366-71. PubMed ID: 21455546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis.
    Fotiou K; Hofmann M; Kaufmann R; Thaci D
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2356-62. PubMed ID: 26332649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.
    Sojević Timotijević Z; Majcan P; Trajković G; Relić M; Novaković T; Mirković M; Djurić S; Nikolić S; Lazić B; Janković S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):215-222. PubMed ID: 29252174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time Spent per delta PASI (TSdP) among psoriasis patients undergoing UVB-therapy - A pilot study.
    Ring HC; Randskov Vinding G; Miller IM; Jemec GB
    J Dermatolog Treat; 2015 Oct; 26(5):415-7. PubMed ID: 25790849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of weekly and daily incremental protocols of narrowband ultraviolet B phototherapy for psoriasis.
    Altiner DD; Ilknur T; Fetil E; Günes AT; Ozkan S
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1076-80. PubMed ID: 16987261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
    Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
    Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
    Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 9 promoter polymorphism as a predictive factor of narrow-band UVB phototherapy response in patients with psoriasis.
    Romaní J; Julià M; Lozano F; Muñoz-Santos C; Guilabert A; Carrascosa JM; Rigla M; Luelmo J
    Photodermatol Photoimmunol Photomed; 2015 Mar; 31(2):98-103. PubMed ID: 25561051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
    Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
    Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrowband UVB treatment increases serum 25-hydroxyvitamin D levels in patients with chronic plaque psoriasis.
    Saleky S; Bulur I; Saraçoğlu ZN
    Cutis; 2017 Jun; 99(6):431-435. PubMed ID: 28686753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of narrow-band UVB phototherapy on soluble cell adhesion molecules in patients with psoriasis vulgaris.
    Long JW; Tao J; Pi XM; Wang YY; Tu YT
    J Int Med Res; 2010; 38(4):1507-12. PubMed ID: 20926025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
    Lui H; Gulliver W; Tan J; Hong CH; Hull P; Shear NH; Paradiso-Hardy F; Bissonette R
    J Drugs Dermatol; 2012 Aug; 11(8):929-37. PubMed ID: 22859237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.
    Feldmeyer L; Shojaati G; Spanaus KS; Navarini A; Theler B; Donghi D; Urosevic-Maiwald M; Glatz M; Imhof L; Barysch MJ; Dummer R; Roos M; French LE; Surber C; Hofbauer GF
    J Am Acad Dermatol; 2013 Oct; 69(4):530-6. PubMed ID: 23850091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.